Cheng L - Search Results

1

Isoliensinine induces cervical cancer cell cycle arrest and apoptosis by inhibiting the AKT/GSK3α pathway.

Li HL, Cheng Y, Zhou ZW, Long HZ, Luo HY, Wen DD, Cheng L, Gao LC. Li HL, et al. Among authors: cheng y, cheng l. Oncol Lett. 2022 Jan;23(1):8. doi: 10.3892/ol.2021.13126. Epub 2021 Nov 9. Oncol Lett. 2022. PMID: 34820007 Free PMC article.

2

A hederagenin saponin isolated from Clematis ganpiniana induces apoptosis in breast cancer cells via the mitochondrial pathway.

Cheng L, Shi L, Wu J, Zhou X, Li X, Sun X, Zhu L, Xia TS, Ding Q. Cheng L, et al. Oncol Lett. 2018 Feb;15(2):1737-1743. doi: 10.3892/ol.2017.7494. Epub 2017 Nov 27. Oncol Lett. 2018. PMID: 29434869 Free PMC article.

3

A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.

Cheng L, Jiang H, Fan J, Wang J, Hu P, Ruan Y, Liu R. Cheng L, et al. Oncol Lett. 2018 May;15(5):7046-7052. doi: 10.3892/ol.2018.8247. Epub 2018 Mar 13. Oncol Lett. 2018. PMID: 29849789 Free PMC article.

4

Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo.

Fan J, Jiang H, Cheng L, Ma B, Liu R. Fan J, et al. Among authors: cheng l. Oncol Lett. 2021 Feb;21(2):99. doi: 10.3892/ol.2020.12360. Epub 2020 Dec 8. Oncol Lett. 2021. PMID: 33376532 Free PMC article.

5

The oncolytic herpes simplex virus vector, G47Δ, effectively targets tamoxifen-resistant breast cancer cells.

Fan J, Jiang H, Cheng L, Liu R. Fan J, et al. Among authors: cheng l. Oncol Rep. 2016 Mar;35(3):1741-9. doi: 10.3892/or.2015.4539. Epub 2015 Dec 30. Oncol Rep. 2016. PMID: 26718317

6

D Rhamnose β-Hederin against human breast cancer by reducing tumor-derived exosomes.

Chen WX, Cheng L, Pan M, Qian Q, Zhu YL, Xu LY, Ding Q. Chen WX, et al. Among authors: cheng l. Oncol Lett. 2018 Oct;16(4):5172-5178. doi: 10.3892/ol.2018.9254. Epub 2018 Aug 2. Oncol Lett. 2018. PMID: 30250584 Free PMC article.

7

Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer.

Chen WX, Lou M, Cheng L, Qian Q, Xu LY, Sun L, Zhu YL, Dai H. Chen WX, et al. Among authors: cheng l. Oncol Lett. 2019 Dec;18(6):6017-6025. doi: 10.3892/ol.2019.10949. Epub 2019 Oct 2. Oncol Lett. 2019. PMID: 31788076 Free PMC article.

8

MicroRNA‑663b mediates TAM resistance in breast cancer by modulating TP73 expression.

Jiang H, Cheng L, Hu P, Liu R. Jiang H, et al. Among authors: cheng l. Mol Med Rep. 2018 Jul;18(1):1120-1126. doi: 10.3892/mmr.2018.9064. Epub 2018 May 23. Mol Med Rep. 2018. PMID: 29845295

9

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells.

Jiang H, Fan J, Cheng L, Hu P, Liu R. Jiang H, et al. Among authors: cheng l. Onco Targets Ther. 2018 Nov 14;11:8153-8163. doi: 10.2147/OTT.S182239. eCollection 2018. Onco Targets Ther. 2018. PMID: 30532556 Free PMC article.

10

Correlation study of serum lipid levels and lipid metabolism-related genes in cervical cancer.

Cheng L, Li Z, Zheng Q, Yao Q. Cheng L, et al. Front Oncol. 2024 May 8;14:1384778. doi: 10.3389/fonc.2024.1384778. eCollection 2024. Front Oncol. 2024. PMID: 38779100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,876 results

Search Page

Filters